[2-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-[1-[5-(diaminomethylideneamino)pentylamino]-1-oxoundecan-3-yl]sulfamic acid
| Internal ID | 27c8e5d9-1071-4e42-8564-b067239a5c4f |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Peptoid-peptide hybrids |
| IUPAC Name | [2-[[(2S)-1-[4-(diaminomethylideneamino)butylamino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-[1-[5-(diaminomethylideneamino)pentylamino]-1-oxoundecan-3-yl]sulfamic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C30H62N10O6S/c1-4-5-6-7-8-10-15-24(21-26(41)35-16-11-9-12-18-37-29(31)32)40(47(44,45)46)22-27(42)39-25(20-23(2)3)28(43)36-17-13-14-19-38-30(33)34/h23-25H,4-22H2,1-3H3,(H,35,41)(H,36,43)(H,39,42)(H4,31,32,37)(H4,33,34,38)(H,44,45,46)/t24?,25-/m0/s1 |
| InChI Key | YSAXACLDKBJDCG-BBMPLOMVSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C30H62N10O6S |
| Molecular Weight | 690.90 g/mol |
| Exact Mass | 690.45745091 g/mol |
| Topological Polar Surface Area (TPSA) | 282.00 Ų |
| XlogP | 1.40 |
| Atomic LogP (AlogP) | 0.86 |
| H-Bond Acceptor | 7 |
| H-Bond Donor | 8 |
| Rotatable Bonds | 28 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.4587 | 45.87% |
| Caco-2 | - | 0.8559 | 85.59% |
| Blood Brain Barrier | - | 0.5250 | 52.50% |
| Human oral bioavailability | - | 0.6714 | 67.14% |
| Subcellular localzation | Mitochondria | 0.4737 | 47.37% |
| OATP2B1 inhibitior | - | 0.5680 | 56.80% |
| OATP1B1 inhibitior | + | 0.8972 | 89.72% |
| OATP1B3 inhibitior | + | 0.9393 | 93.93% |
| MATE1 inhibitior | - | 0.7200 | 72.00% |
| OCT2 inhibitior | - | 0.7500 | 75.00% |
| BSEP inhibitior | + | 0.8410 | 84.10% |
| P-glycoprotein inhibitior | + | 0.6952 | 69.52% |
| P-glycoprotein substrate | + | 0.8611 | 86.11% |
| CYP3A4 substrate | + | 0.6458 | 64.58% |
| CYP2C9 substrate | + | 0.5918 | 59.18% |
| CYP2D6 substrate | - | 0.8409 | 84.09% |
| CYP3A4 inhibition | - | 0.9436 | 94.36% |
| CYP2C9 inhibition | - | 0.7360 | 73.60% |
| CYP2C19 inhibition | - | 0.6928 | 69.28% |
| CYP2D6 inhibition | - | 0.8678 | 86.78% |
| CYP1A2 inhibition | - | 0.7946 | 79.46% |
| CYP2C8 inhibition | - | 0.6877 | 68.77% |
| CYP inhibitory promiscuity | - | 0.9819 | 98.19% |
| UGT catelyzed | - | 0.0000 | 0.00% |
| Carcinogenicity (binary) | - | 0.5100 | 51.00% |
| Carcinogenicity (trinary) | Non-required | 0.6250 | 62.50% |
| Eye corrosion | - | 0.9729 | 97.29% |
| Eye irritation | - | 0.9077 | 90.77% |
| Skin irritation | - | 0.7584 | 75.84% |
| Skin corrosion | - | 0.9079 | 90.79% |
| Ames mutagenesis | - | 0.6037 | 60.37% |
| Human Ether-a-go-go-Related Gene inhibition | - | 0.7172 | 71.72% |
| Micronuclear | + | 0.8500 | 85.00% |
| Hepatotoxicity | - | 0.6165 | 61.65% |
| skin sensitisation | - | 0.8162 | 81.62% |
| Respiratory toxicity | + | 0.6222 | 62.22% |
| Reproductive toxicity | - | 0.6111 | 61.11% |
| Mitochondrial toxicity | + | 0.7500 | 75.00% |
| Nephrotoxicity | + | 0.5358 | 53.58% |
| Acute Oral Toxicity (c) | III | 0.5415 | 54.15% |
| Estrogen receptor binding | + | 0.6862 | 68.62% |
| Androgen receptor binding | + | 0.6114 | 61.14% |
| Thyroid receptor binding | + | 0.5868 | 58.68% |
| Glucocorticoid receptor binding | + | 0.5758 | 57.58% |
| Aromatase binding | + | 0.6182 | 61.82% |
| PPAR gamma | + | 0.6250 | 62.50% |
| Honey bee toxicity | - | 0.8809 | 88.09% |
| Biodegradation | - | 0.6500 | 65.00% |
| Crustacea aquatic toxicity | + | 0.7226 | 72.26% |
| Fish aquatic toxicity | + | 0.9256 | 92.56% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.79% | 98.95% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 97.37% | 93.56% |
| CHEMBL240 | Q12809 | HERG | 97.17% | 89.76% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 97.05% | 85.31% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 96.95% | 97.29% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 96.71% | 99.17% |
| CHEMBL4462 | Q8IXJ6 | NAD-dependent deacetylase sirtuin 2 | 96.62% | 90.24% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 96.25% | 91.81% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 95.96% | 96.09% |
| CHEMBL261 | P00915 | Carbonic anhydrase I | 95.35% | 96.76% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 94.72% | 98.05% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 93.76% | 90.71% |
| CHEMBL4769 | O95749 | Geranylgeranyl pyrophosphate synthetase | 93.29% | 92.08% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 92.98% | 100.00% |
| CHEMBL4685 | P14902 | Indoleamine 2,3-dioxygenase | 92.80% | 96.38% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 92.79% | 96.00% |
| CHEMBL3837 | P07711 | Cathepsin L | 92.49% | 96.61% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 92.26% | 97.21% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 90.93% | 92.86% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 90.14% | 96.25% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 90.12% | 96.95% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 90.08% | 92.29% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 89.61% | 96.47% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 89.34% | 97.23% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 89.33% | 100.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 89.09% | 91.19% |
| CHEMBL4040 | P28482 | MAP kinase ERK2 | 88.96% | 83.82% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 88.39% | 100.00% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 87.94% | 96.67% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 87.93% | 89.63% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 87.09% | 83.10% |
| CHEMBL255 | P29275 | Adenosine A2b receptor | 86.96% | 98.59% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 86.94% | 91.11% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.59% | 96.90% |
| CHEMBL1795117 | Q8TEK3 | Histone-lysine N-methyltransferase, H3 lysine-79 specific | 86.08% | 93.56% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 85.87% | 98.33% |
| CHEMBL205 | P00918 | Carbonic anhydrase II | 85.47% | 98.44% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 84.38% | 90.17% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 83.98% | 96.00% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 83.45% | 94.33% |
| CHEMBL3891 | P07384 | Calpain 1 | 83.43% | 93.04% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 83.14% | 94.73% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 82.92% | 93.10% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 82.77% | 100.00% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 82.68% | 86.67% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 82.59% | 89.33% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 82.54% | 95.17% |
| CHEMBL2885 | P07451 | Carbonic anhydrase III | 82.40% | 87.45% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 81.53% | 98.03% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 80.92% | 94.66% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 80.57% | 95.71% |
| CHEMBL1255126 | O15151 | Protein Mdm4 | 80.19% | 90.20% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 80.15% | 98.77% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 80.05% | 95.52% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 10818414 |
| LOTUS | LTS0176473 |
| wikiData | Q105359494 |